The Real Bottleneck in Pharma Isn't What You Think

While the pharmaceutical industry often focuses on intellectual property and drug discovery as the primary hurdles, the true bottleneck lies elsewhere. According to a recent analysis, the most critical challenge is operational execution—specifically, converting potential participants into completed study patients in clinical trials. This complex phase, where protocols meet real-world conditions, determines the success or failure of trials. It is here that the most significant value is captured, making operational efficiency the key to overcoming pharma's biggest obstacle.